Insider Transactions in Q2 2024 at Phreesia, Inc. (PHR)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2024
|
Yvonne Hui Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
740
+4.42%
|
$13,320
$18.02 P/Share
|
|
Jun 28
2024
|
Allison C Hoffman General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
292
+0.21%
|
$5,256
$18.02 P/Share
|
|
Jun 26
2024
|
Michael Weintraub Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,490
+4.3%
|
-
|
|
Jun 26
2024
|
Edward L Cahill Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,490
+13.46%
|
-
|
|
Jun 26
2024
|
Lainie Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,490
+17.45%
|
-
|
|
Jun 26
2024
|
Lisa Egbuonu Davis Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,490
+30.29%
|
-
|
|
Jun 26
2024
|
Mark Douglas Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,490
+21.69%
|
-
|
|
Jun 26
2024
|
Ramin Sayar Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,490
+24.1%
|
-
|
|
Jun 26
2024
|
Gillian Munson Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,490
+19.18%
|
-
|
|
Jun 21
2024
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Indirect |
27
-0.39%
|
$540
$20.24 P/Share
|
|
Jun 21
2024
|
Janet Gunzburg Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
114
-0.33%
|
$2,280
$20.24 P/Share
|
|
Jun 20
2024
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Indirect |
66
-0.94%
|
$1,254
$19.73 P/Share
|
|
Jun 18
2024
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Indirect |
41
-0.58%
|
$779
$19.2 P/Share
|
|
May 01
2024
|
Janet Gunzburg Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
286
-0.81%
|
$6,006
$21.0 P/Share
|
|
Apr 30
2024
|
Edward L Cahill Director |
BUY
Grant, award, or other acquisition
|
Direct |
482
+1.04%
|
$9,640
$20.74 P/Share
|
|
Apr 30
2024
|
Gillian Munson Director |
BUY
Grant, award, or other acquisition
|
Direct |
482
+1.74%
|
$9,640
$20.74 P/Share
|
|
Apr 30
2024
|
Lainie Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
482
+1.5%
|
$9,640
$20.74 P/Share
|
|
Apr 18
2024
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Indirect |
269
-3.66%
|
$5,918
$22.85 P/Share
|
|
Apr 18
2024
|
Janet Gunzburg Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
912
-2.52%
|
$20,064
$22.85 P/Share
|
|
Apr 15
2024
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
1,238
-0.9%
|
$27,236
$22.86 P/Share
|
|
Apr 15
2024
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,029
-0.27%
|
$44,638
$22.86 P/Share
|
|
Apr 15
2024
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
2,212
-1.07%
|
$48,664
$22.86 P/Share
|
|
Apr 15
2024
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
685
-0.57%
|
$15,070
$22.86 P/Share
|
|
Apr 15
2024
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,392
-0.28%
|
$74,624
$22.86 P/Share
|
|
Apr 15
2024
|
Balaji Gandhi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
948
-0.97%
|
$20,856
$22.86 P/Share
|
|
Apr 10
2024
|
Janet Gunzburg Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,768
-7.12%
|
$63,664
$23.1 P/Share
|
|
Apr 09
2024
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
4,626
-3.27%
|
$106,398
$23.42 P/Share
|
|
Apr 09
2024
|
Evan Roberts Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,330
+2.99%
|
$46,660
$2.03 P/Share
|
|
Apr 09
2024
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
3,768
-3.05%
|
$86,664
$23.43 P/Share
|
|
Apr 08
2024
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
12,043
-0.49%
|
$264,946
$22.82 P/Share
|
|
Apr 08
2024
|
Balaji Gandhi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,778
-3.67%
|
$171,116
$22.82 P/Share
|
|
Apr 08
2024
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
5,549
-1.89%
|
$122,078
$22.82 P/Share
|
|
Apr 08
2024
|
Janet Gunzburg Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,709
-2.11%
|
$37,598
$22.82 P/Share
|
|
Apr 08
2024
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Indirect |
247
-1.62%
|
$5,434
$22.82 P/Share
|
|
Apr 08
2024
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
3,914
-0.93%
|
$86,108
$22.82 P/Share
|
|
Apr 08
2024
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,178
-0.48%
|
$157,916
$22.82 P/Share
|
|
Apr 08
2024
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
3,354
-1.32%
|
$73,788
$22.82 P/Share
|
|
Apr 05
2024
|
Janet Gunzburg Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,477
+9.35%
|
-
|
|
Apr 05
2024
|
Amy Beth Van Duyn SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
7,122
+5.32%
|
-
|
|
Apr 05
2024
|
David Linetsky SVP, Life Sciences |
BUY
Grant, award, or other acquisition
|
Indirect |
508
+6.26%
|
-
|
|
Apr 05
2024
|
David Linetsky SVP, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
6,105
+2.82%
|
-
|
|
Apr 05
2024
|
Balaji Gandhi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,926
+10.12%
|
-
|
|
Apr 05
2024
|
Evan Roberts Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,210
+1.62%
|
-
|
|
Apr 05
2024
|
Allison C Hoffman General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
10,175
+6.47%
|
-
|
|
Apr 05
2024
|
Chaim Indig Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,961
+1.67%
|
-
|